ProfileGDS4814 / ILMN_1688279
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 2% 3% 1% 1% 1% 2% 9% 4% 2% 17% 6% 22% 1% 5% 13% 22% 14% 1% 20% 10% 15% 1% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)37.14992
GSM780708Untreated after 4 days (C2_1)38.53883
GSM780709Untreated after 4 days (C3_1)36.21711
GSM780719Untreated after 4 days (C1_2)36.14821
GSM780720Untreated after 4 days (C2_2)36.42681
GSM780721Untreated after 4 days (C3_2)37.09842
GSM780710Trastuzumab treated after 4 days (T1_1)40.98959
GSM780711Trastuzumab treated after 4 days (T2_1)39.12244
GSM780712Trastuzumab treated after 4 days (T3_1)37.1382
GSM780722Trastuzumab treated after 4 days (T1_2)42.819217
GSM780723Trastuzumab treated after 4 days (T2_2)39.97166
GSM780724Trastuzumab treated after 4 days (T3_2)43.930222
GSM780713Pertuzumab treated after 4 days (P1_1)33.11661
GSM780714Pertuzumab treated after 4 days (P2_1)39.33735
GSM780715Pertuzumab treated after 4 days (P3_1)42.03613
GSM780725Pertuzumab treated after 4 days (P1_2)43.882622
GSM780726Pertuzumab treated after 4 days (P2_2)42.139414
GSM780727Pertuzumab treated after 4 days (P3_2)35.78291
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)43.527820
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)41.224510
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)42.500815
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)36.96581
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)40.68658